a period of one year: from September 6, 1971, to September 5,1972 , with regard to men and from November 1, 1971 , to October 31, 1972 , with regard to women.
Gonorrhoea was diagnosed by direct microscopy and/or culture. Specimens were collected at all visits: from the urethra in males and from the urethra, cervix, and rectum in females. The prostate gland was palpated in all males; if this was abnormal the case was counted as complicated and excluded from the series. In addition, specimens were collected from women at the first visit for Trichomonas and Candida cultures (Eriksson and Wanger, 1975) .
Patients were treated alternately with either 2 g. ampicillin (Doktacilling), Astra Lakemedel AB, Sweden) administered orally in two doses with a 5-hour interval or 0-3 g. doxycycline (Vibramycing, Pfizer AB, Sweden) in a single oral dose with a glass of water. Any patient hypersensitive to penicillin who was next in turn for ampicillin was dropped from the study. Pregnant women coming next in turn for doxyxycline therapy were also excluded. In addition, patients who vomited within a period of 2 hours after taking the drug were also eliminated from the statistical analysis because treatment failures in such cases could be due to inadequate absorption of the drug. If microscopy was positive, treatment was started without awaiting the results of cultures and sensitivity tests.
A positive rectal culture in women was not regarded as a complication, as previously (Eriksson, 1971a) , and patients with this were therefore included.
Patients were asked to return for follow-up examinations once a week. In accordance with the Swedish Law against Infectious Diseases, patients infected by gonococcal strains with normal antibiotic sensitivity were recalled for two follow-up examinations, and those affected by less sensitive strains for four. Patients were also questioned regarding side-effects of the drug.
Specimens were cultured on Thayer-Martin medium. In vitro sensitivity tests were performed on all positive cultures for penicillin G, ampicillin, streptomycin, and tetracycline throughout the trial, and for doxycycline from January 1, 1972. Strains for which the MIC was >0-1 jig. ampicillin per ml. and >1-0 [ug. tetracycline per ml. respectively were classified as "less sensitive".
Strains for which the MIC was >3 [Lg. streptomycin per ml. were classified as resistant.
When treatment was concluded the relevant data was recorded on special forms and processed in the manner described by Eriksson and others (1975 
COMPARISON OF THE RESULTS OF TREATMENT
Ampicillin is thus significantly better than doxycycline both for males (P <0-001) and females (0 05> P> 0-01). For both sexes combined the failure rates were 1 1 and 741 per cent. respectively (P < 001). In vitro determinations of sensitivity to doxycycline were carried out in about eighty cases and were similar to the tetracycline sensitivities.
In the doxycycline group 24/118 (20 3 per cent.) of patients infected with N. gonorrhoeae less sensitive to ampiciLlin relapsed but only 5/281 (1 8 per cent.) in the sensitive group. This difference is highly significant (x2 = 37-76; P<0-001). 
Discussion
In previous reports it has been shown that oral ampicillin administered in two doses of 1 g. with a 5-hour interval, provides effective treatment of uncomplicated gonorrhoea in both men and women, giving a treatment failure rate of only 1-5 per cent. (Eriksson and Wallmark, 1972; Eriksson, 1973 ). The present investigation shows that this type of oral ampicillin therapy, with a failure rate of 1 1 per cent., still gives excellent results in the same geographical area 3 years later (Eriksson, 1970a (Eriksson, , b, 1971a .
The percentage of strains with reduced sensitivity to ampicillin (MICGO1 [kg./ml.) was 16 per cent. in the earlier series (Eriksson and Wallmark, 1972) In this investigation, 26-9 per cent. of the gonococcal strains showed reduced sensitivity to ampicillin in the group treated with ampicillin, and 28-2 per cent. in the entire series. The sensitivity of gonococcal strains to different penicillins will be reported in greater detail in a 2-year study (Eriksson and Wallmark, to be published). Any tendency towards reduced sensitivity to ampicillin, has not as yet had any practical therapeutic consequences. (Lassus, 1968; Moffett, McGill, Masterton, and Schofield, 1972; Petzoldt, 1972; Masterton and Schofield, 1972; Gallai, Sylvestre, and Brault, 1970) and of 2-4 per cent. in a series consisting of both males and females (Liden, Hammar, Hillstrom, Wallin, and Ohman, 1971) . Others have obtained considerably poorer results, however, with failure rates of 12 7 to 49 per cent. (Gray, Phillips, and Nicol, 1970; Mutchnik, 1972; Baytch and Rankin, 1972; and Jones and Gilleland, 1971) . In our study the relapse rate was 8-1 per cent. in males, 5-7 per cent. in females, and 7-1 per cent. overall. Although these results rank among the best reported in the literature, they are still inferior to those obtained with ampicillin, so that we are not inclined to accept doxycycline 0 3 g. in a single oral dose as an entirely suitable form of treatment.
In this study the failure rate was significantly higher in doxycycline-treated patients infected by gonococcal strains showing in vitro resistance to streptomycin than in those with strains sensitive to streptomycin. Liden and others (1971) stated that three of their six relapsing patients were infected by strains resistant to streptomycin, whereas the overall frequency of such strains was only 12/250 (4-8 per cent.). The low incidence of gonococcal strains showing resistance to streptomycin in vitro could be the reason for their better therapeutic results. It might be possible to utilize the sensitivity of gonococcal strains to streptomycin in vitro as a guide to which patients should be treated with doxycycline in a single dose. Patients with streptomycin-sensitive strains appear to be well suited for such treatment when penicillin cannot be used, but this is not the case in those with streptomycin-resistant strains.
The in vitro sensitivity of gonococcal strains to tetracycline provided little guidance as to the outcome of doxycycline therapy. 2-2 per cent. (9/403) had reduced tetracycline sensitivity when an MICG1>0 Fg./ml. was taken as the criterion. It is true that three of the relapses occurred in this group, but the remaining 26 relapses were in the fully sensitive group. If the threshold for reduced tetracycline sensitivity were lowered to the same level as that now used for penicillin G and ampicillin (viz. MICG01 Vg./ml.), 96-2 per cent. of the strains in this series would have been rated as 'less sensitive'. Such an alteration of the threshold would not, then, have any practical clinical significance.
Maness and Sparling (1973) found that sensitivities to tetracycline and doxycycine were nearly identical.
This was also found to be the case in the present series, but only eighty strains were tested for sensitivity to doxycycline.
Owing to the high incidence of side-effects, the dose of doxycycline used in single-dose therapy cannot be increased.
Even with the dosage employed the incidence of vomiting was 5 per cent. (27/545), and an additional forty patients (7.3 per cent.) reported severe nausea.
Summary
An account is given of a computer-processed 1-year study comprising 1,124 patients (625 males and 499 females) with uncomplicated gonorrhoea. Alternate patients were treated with either two oral doses of 1 g. ampicilWin 5 hours apart, or 0-3 g. doxycycline in a single oral dose. Ampicillin remained as efficacious as in 1968 to 1970, in both males and females, in whom the failure rates were 1 1 and 1 per cent. respectively. After doxycycline the failure rate was 8-1 per cent. in males, 5-7 per cent. in females, and 7-1 per cent. overall. Ampicillin was significantly better than doxycycline in the treatment of men (P<0-001) as well as of women (0-05>P>0-01). 89-7 per cent. (26/29) of the relapses in doxycycinetreated patients occurred in those harbouring strains sensitive to tetracycline. Sensitivity to doxycycline followed the pattern of tetracycline sensitivity. Thus sensitivity tests with these antibiotics provided no practical aid to therapy. The high incidence of nausea and vomiting in patients treated with doxycycline (12 per cent.) makes it inadvisable to increase the dose; instead, multiple doses are necessary to obtain satisfactory results. There were very few adverse reactions to ampicillin; a rash occurred in only three patients (0-5 per cent.).
In the group treated with doxycycline, 31-5 per cent. of the patients infected by streptomycinresistant strains relapsed compared with only 1-8 per cent. of patients infected by streptomycin-sensitive strains. This difference is highly significant (P< 0-001 qu'en 1968-70 , aussi bien chez la femme que chez l'homme et les taux d'echec furent respectivement de 1,1 pour cent et de 1,0 pour cent. Avec la doxycycline, le taux d'&chec fut de 8,1 pour cent chez les hommes et de 5,7 pour cent chez les femmes, soit 7,1 pour cent au total. L'ampicilline fut significativement meilleure que la doxycycline pour le traitement des hommes (P < 0,001) aussi bien que des femmes (0,05 > P > 0,01). On observa 89,7 pour cent de rechutes chez les malades traites par la doxycycline lorsqu'ils etaient infectes par des souches sensibles a la tetracycline. La sensibilite a la doxycycline fut du meme type que la sensibilite a la tetracycline. Ainsi, les epreuves de sensibilite avec ces antibiotiques n'apportent pas d'aide pratique au traitement. L'incidence elevee de nausees et de vomissements chez les malades traites par la doxycycline (12 pour cent) empeche de conseiller une augmentation de la dose; au lieu de cela, des doses multiples sont necessaires pour obtenir des resultats satisfaisants. IL y eut tres peu de reactions a l'ampicilline; une eruption fut seulement observee chez 3 malades (0,5 pour cent).
Dans le groupe traite par la doxycycline 31,5 des malades infectes par des souches streptomycinoresistantes rechuterent contre seulement 1,8 pour cent des malades infectes par des souches streptomycino-sensibles. La difference est hautement significative (P < 0,001) ainsi, la sensibilite in vitro des souches a la streptomycine peut etre un guide valable pour apprecier les chances de resultat du traitement par les tetracyclines. 
